Brennan to chair PhRMA board, with Kindler waiting in the wings

Share this article:
David Brennan
David Brennan
PhRMA's board of directors elected AstraZeneca chief David Brennan as this year's board chairman and Pfizer chairman and CEO Jeff Kindler chairman-elect. Johnson & Johnson's David Norton, company group chairman, worldwide commercial and operations, Pharmaceuticals Group, was elected board treasurer.

Brennan succeeds Merck president and CEO Richard Clark as PhRMA chairman. The votes came at PhRMA's annual meeting in Washington, DC.

In a statement, Clark said: “The PhRMA member companies accomplished much this pas year. We strengthened our marketing code, tightened our DTC advertising principles and voiced strong support of transparency of company interactions with physicians.”

The agenda for the meeting included discussion of policy issues, including healthcare reform and global intellectual property law, as well as medical innovation.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.